CLHICanadian Lifelong Health Initiative (genetic and environmental study; Canadian Institutes of Health Research)
References in periodicals archive ?
Since CLHI had previously adopted a plan to liquidate, it does not appear to us that the net operating loss carry forward or NOL will ever benefit the current shareholders.
In light of the actions taken by CLHI in adopting its rights plan, Red Oak is abandoning its previously announced plan to commence a tender offer for CLHI shares.
As noted, the scenarios outlined in this article do not involve genetic information, although its collection is integral to the design of research platforms like Biobank and CLHI.